- Home
- PPSI vs BNR Comparison
PPSI vs BNR Comparison
Compare PPSI & BNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PPSI
- BNR
- Stock Information
- Founded
- PPSI 2008
- BNR 2014
- Country
- PPSI United States
- BNR China
- Employees
- PPSI N/A
- BNR N/A
- Industry
- PPSI Electrical Products
- BNR Medical Specialities
- Sector
- PPSI Industrials
- BNR Health Care
- Exchange
- PPSI Nasdaq
- BNR Nasdaq
- Market Cap
- PPSI 30.0M
- BNR 29.1M
- IPO Year
- PPSI N/A
- BNR 2020
- Fundamental
- Price
- PPSI $2.68
- BNR $3.10
- Analyst Decision
- PPSI Strong Buy
- BNR
- Analyst Count
- PPSI 1
- BNR 0
- Target Price
- PPSI $12.00
- BNR N/A
- AVG Volume (30 Days)
- PPSI 57.4K
- BNR 67.9K
- Earning Date
- PPSI 05-15-2025
- BNR 06-10-2025
- Dividend Yield
- PPSI 55.97%
- BNR N/A
- EPS Growth
- PPSI N/A
- BNR N/A
- EPS
- PPSI 2.84
- BNR N/A
- Revenue
- PPSI $26,304,000.00
- BNR $70,669,261.00
- Revenue This Year
- PPSI $23.90
- BNR $136.32
- Revenue Next Year
- PPSI $19.35
- BNR N/A
- P/E Ratio
- PPSI $0.94
- BNR N/A
- Revenue Growth
- PPSI 439.46
- BNR N/A
- 52 Week Low
- PPSI $2.25
- BNR $2.18
- 52 Week High
- PPSI $7.00
- BNR $7.90
- Technical
- Relative Strength Index (RSI)
- PPSI 48.06
- BNR 51.73
- Support Level
- PPSI $2.61
- BNR $2.99
- Resistance Level
- PPSI $2.89
- BNR $3.45
- Average True Range (ATR)
- PPSI 0.21
- BNR 0.34
- MACD
- PPSI 0.00
- BNR 0.10
- Stochastic Oscillator
- PPSI 31.88
- BNR 70.59
About PPSI Pioneer Power Solutions Inc.
Pioneer Power Solutions Inc designs, manufactures, integrates, services, and sells distributed energy resources, on-site and mobile power generation equipment, and a platform of mobile electric vehicle (EV) charging solutions.. Its principal products and services include custom-engineered electrical transformers, switchgear and engine-generator sets and controls, complemented by a national field-service network to maintain and repair power generation assets.
About BNR Burning Rock Biotech Limited
Burning Rock Biotech Ltd is a cancer diagnostics company. It is a NGS-based cancer therapy selection company. Its cancer therapy selection platform is built upon advanced proprietary technologies, comprehensive portfolio of products and a two-pronged market-driven commercial infrastructure addressing both larger hospitals through our in-hospital model and smaller hospitals through our central laboratory model. It had three operating segments, including Central laboratory business, In-hospital business and Pharma research and development services. It generates the majority of its revenue from Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, brPROPHET, OncoScreen Plus, and others.